- Home
- KIRK vs PULM Comparison
KIRK vs PULM Comparison
Compare KIRK & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIRK
- PULM
- Stock Information
- Founded
- KIRK 1966
- PULM 2003
- Country
- KIRK United States
- PULM United States
- Employees
- KIRK N/A
- PULM N/A
- Industry
- KIRK Diversified Commercial Services
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- KIRK Miscellaneous
- PULM Health Care
- Exchange
- KIRK Nasdaq
- PULM Nasdaq
- Market Cap
- KIRK 26.7M
- PULM 33.2M
- IPO Year
- KIRK 2002
- PULM N/A
- Fundamental
- Price
- KIRK $1.21
- PULM $6.40
- Analyst Decision
- KIRK Buy
- PULM
- Analyst Count
- KIRK 2
- PULM 0
- Target Price
- KIRK $4.50
- PULM N/A
- AVG Volume (30 Days)
- KIRK 193.4K
- PULM 59.3K
- Earning Date
- KIRK 09-04-2025
- PULM 08-12-2025
- Dividend Yield
- KIRK N/A
- PULM N/A
- EPS Growth
- KIRK N/A
- PULM N/A
- EPS
- KIRK N/A
- PULM N/A
- Revenue
- KIRK $431,111,000.00
- PULM $1,921,000.00
- Revenue This Year
- KIRK N/A
- PULM N/A
- Revenue Next Year
- KIRK N/A
- PULM $134.88
- P/E Ratio
- KIRK N/A
- PULM N/A
- Revenue Growth
- KIRK N/A
- PULM N/A
- 52 Week Low
- KIRK $1.05
- PULM $1.78
- 52 Week High
- KIRK $2.50
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- KIRK 56.05
- PULM 39.73
- Support Level
- KIRK $1.16
- PULM $6.28
- Resistance Level
- KIRK $1.23
- PULM $6.96
- Average True Range (ATR)
- KIRK 0.04
- PULM 0.44
- MACD
- KIRK 0.01
- PULM -0.08
- Stochastic Oscillator
- KIRK 88.72
- PULM 8.10
About KIRK Kirkland's Inc. COMMONSTOCK
Kirkland's Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).